位置:首页 > 蛋白库 > OSH6_YEAST
OSH6_YEAST
ID   OSH6_YEAST              Reviewed;         448 AA.
AC   Q02201; D6VXT9;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1993, sequence version 1.
DT   03-AUG-2022, entry version 168.
DE   RecName: Full=Oxysterol-binding protein homolog 6 {ECO:0000303|PubMed:11238399};
DE   AltName: Full=Lipid-transfer protein Osh6;
DE            Short=LTP;
DE   AltName: Full=Oxysterol-binding phosphatidylserine transferase;
DE   AltName: Full=Oxysterol-binding protein-related protein 6;
DE            Short=ORP 6;
DE            Short=OSBP-related protein 6;
GN   Name=OSH6 {ECO:0000303|PubMed:11238399}; OrderedLocusNames=YKR003W;
GN   ORFNames=YK102;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC   Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=1441752; DOI=10.1002/yea.320080908;
RA   Duesterhoeft A., Philippsen P.;
RT   "DNA sequencing and analysis of a 24.7 kb segment encompassing centromere
RT   CEN11 of Saccharomyces cerevisiae reveals nine previously unknown open
RT   reading frames.";
RL   Yeast 8:749-759(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=8196765; DOI=10.1038/369371a0;
RA   Dujon B., Alexandraki D., Andre B., Ansorge W., Baladron V.,
RA   Ballesta J.P.G., Banrevi A., Bolle P.-A., Bolotin-Fukuhara M., Bossier P.,
RA   Bou G., Boyer J., Buitrago M.J., Cheret G., Colleaux L.,
RA   Daignan-Fornier B., del Rey F., Dion C., Domdey H., Duesterhoeft A.,
RA   Duesterhus S., Entian K.-D., Erfle H., Esteban P.F., Feldmann H.,
RA   Fernandes L., Fobo G.M., Fritz C., Fukuhara H., Gabel C., Gaillon L.,
RA   Garcia-Cantalejo J.M., Garcia-Ramirez J.J., Gent M.E., Ghazvini M.,
RA   Goffeau A., Gonzalez A., Grothues D., Guerreiro P., Hegemann J.H.,
RA   Hewitt N., Hilger F., Hollenberg C.P., Horaitis O., Indge K.J.,
RA   Jacquier A., James C.M., Jauniaux J.-C., Jimenez A., Keuchel H.,
RA   Kirchrath L., Kleine K., Koetter P., Legrain P., Liebl S., Louis E.J.,
RA   Maia e Silva A., Marck C., Monnier A.-L., Moestl D., Mueller S.,
RA   Obermaier B., Oliver S.G., Pallier C., Pascolo S., Pfeiffer F.,
RA   Philippsen P., Planta R.J., Pohl F.M., Pohl T.M., Poehlmann R.,
RA   Portetelle D., Purnelle B., Puzos V., Ramezani Rad M., Rasmussen S.W.,
RA   Remacha M.A., Revuelta J.L., Richard G.-F., Rieger M.,
RA   Rodrigues-Pousada C., Rose M., Rupp T., Santos M.A., Schwager C.,
RA   Sensen C., Skala J., Soares H., Sor F., Stegemann J., Tettelin H.,
RA   Thierry A., Tzermia M., Urrestarazu L.A., van Dyck L.,
RA   van Vliet-Reedijk J.C., Valens M., Vandenbol M., Vilela C., Vissers S.,
RA   von Wettstein D., Voss H., Wiemann S., Xu G., Zimmermann J., Haasemann M.,
RA   Becker I., Mewes H.-W.;
RT   "Complete DNA sequence of yeast chromosome XI.";
RL   Nature 369:371-378(1994).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [4]
RP   GENETIC ANALYSIS.
RX   PubMed=11238399; DOI=10.1093/genetics/157.3.1117;
RA   Beh C.T., Cool L., Phillips J., Rine J.;
RT   "Overlapping functions of the yeast oxysterol-binding protein homologues.";
RL   Genetics 157:1117-1140(2001).
RN   [5]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N.,
RA   O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [6]
RP   FUNCTION.
RX   PubMed=15173322; DOI=10.1242/jcs.01157;
RA   Beh C.T., Rine J.;
RT   "A role for yeast oxysterol-binding protein homologs in endocytosis and in
RT   the maintenance of intracellular sterol-lipid distribution.";
RL   J. Cell Sci. 117:2983-2996(2004).
RN   [7]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH VPS4.
RX   PubMed=16096648; DOI=10.1038/sj.emboj.7600764;
RA   Wang P., Zhang Y., Li H., Chieu H.K., Munn A.L., Yang H.;
RT   "AAA ATPases regulate membrane association of yeast oxysterol binding
RT   proteins and sterol metabolism.";
RL   EMBO J. 24:2989-2999(2005).
RN   [8]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16156791; DOI=10.1111/j.1742-4658.2005.04886.x;
RA   Wang P., Duan W., Munn A.L., Yang H.;
RT   "Molecular characterization of Osh6p, an oxysterol binding protein homolog
RT   in the yeast Saccharomyces cerevisiae.";
RL   FEBS J. 272:4703-4715(2005).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17287358; DOI=10.1073/pnas.0607084104;
RA   Chi A., Huttenhower C., Geer L.Y., Coon J.J., Syka J.E.P., Bai D.L.,
RA   Shabanowitz J., Burke D.J., Troyanskaya O.G., Hunt D.F.;
RT   "Analysis of phosphorylation sites on proteins from Saccharomyces
RT   cerevisiae by electron transfer dissociation (ETD) mass spectrometry.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:2193-2198(2007).
RN   [10]
RP   SUBCELLULAR LOCATION.
RX   PubMed=20008566; DOI=10.1083/jcb.200905007;
RA   Schulz T.A., Choi M.G., Raychaudhuri S., Mears J.A., Ghirlando R.,
RA   Hinshaw J.E., Prinz W.A.;
RT   "Lipid-regulated sterol transfer between closely apposed membranes by
RT   oxysterol-binding protein homologues.";
RL   J. Cell Biol. 187:889-903(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) IN COMPLEX WITH PHOSPHATIDYLSERINE,
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF LEU-69; THR-71; ILE-73;
RP   LYS-126; ASN-129; HIS-157; HIS-158; LYS-182 AND LYS-351.
RX   PubMed=23934110; DOI=10.1038/nature12430;
RA   Maeda K., Anand K., Chiapparino A., Kumar A., Poletto M., Kaksonen M.,
RA   Gavin A.C.;
RT   "Interactome map uncovers phosphatidylserine transport by oxysterol-binding
RT   proteins.";
RL   Nature 501:257-261(2013).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.55 ANGSTROMS) IN COMPLEX WITH PHOSPHATIDYLINOSITOL
RP   4-PHOSPHATE, FUNCTION, AND MUTAGENESIS OF LEU-69; 157-HIS-HIS-158 AND
RP   LYS-351.
RX   PubMed=26206936; DOI=10.1126/science.aab1346;
RA   Moser von Filseck J., Copic A., Delfosse V., Vanni S., Jackson C.L.,
RA   Bourguet W., Drin G.;
RT   "Phosphatidylserine transport by ORP/Osh proteins is driven by
RT   phosphatidylinositol 4-phosphate.";
RL   Science 349:432-436(2015).
CC   -!- FUNCTION: Lipid transport protein (LTP) involved in non-vesicular
CC       transfer of lipids between membranes. Functions in phosphoinositide-
CC       coupled directional transport of various lipids by carrying the lipid
CC       molecule in a hydrophobic pocket and transfering it between membranes
CC       through the cytosol. Involved in maintenance of intracellular sterol
CC       distribution and homeostasis (PubMed:15173322, PubMed:16156791,
CC       PubMed:23934110, PubMed:26206936). Catalyzes the lipid countertransport
CC       between the endoplasmic reticulum (ER) and the plasma membrane (PM).
CC       Specifically exchanges phosphatidylserine (PS) with
CC       phosphatidylinositol 4-phosphate (PI4P), delivering phosphatidylserine
CC       to the PM in exchange for PI4P, which is delivered to the ER-localized
CC       PI4P phosphatase SAC1 for degradation. Thus, by maintaining a PI4P
CC       gradient at the ER/PM interface, SAC1 drives PS transport
CC       (PubMed:23934110, PubMed:26206936). Binds phosphatidylserine and PI4P
CC       in a mutually exclusive manner (PubMed:26206936). Also binds
CC       phosphatidic acid (PA) (PubMed:16156791). {ECO:0000269|PubMed:15173322,
CC       ECO:0000269|PubMed:16156791, ECO:0000269|PubMed:23934110,
CC       ECO:0000269|PubMed:26206936}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phospho-L-serine(in) = a 1,2-diacyl-
CC         sn-glycero-3-phospho-L-serine(out); Xref=Rhea:RHEA:38663,
CC         ChEBI:CHEBI:57262; Evidence={ECO:0000269|PubMed:23934110};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38664;
CC         Evidence={ECO:0000269|PubMed:23934110};
CC   -!- SUBUNIT: Interacts with the AAA ATPase VPS4; regulates OSH6 membrane
CC       association. VPS4 is required for membrane dissociation of OSH6.
CC       {ECO:0000269|PubMed:16096648}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16096648,
CC       ECO:0000269|PubMed:16156791}. Cell membrane
CC       {ECO:0000269|PubMed:16156791, ECO:0000269|PubMed:20008566}. Endoplasmic
CC       reticulum membrane {ECO:0000269|PubMed:20008566,
CC       ECO:0000269|PubMed:23934110}. Note=Localizes to the cortical
CC       endoplasmic reticulum at the endoplasmic reticulum-plasma membrane
CC       contact sites. {ECO:0000269|PubMed:20008566,
CC       ECO:0000269|PubMed:23934110}.
CC   -!- DOMAIN: The OSBP-related domain (ORD) mediates binding of sterols and
CC       phospholipids. It displays an incomplete beta-barrel containing a
CC       central hydrophobic tunnel that can accommodate a single lipid molecule
CC       with a flexible lid covering the tunnel entrance. The ORD can bind two
CC       membranes simultaneously. It has at least two membrane-binding
CC       surfaces; one near the mouth of the lipid-binding pocket and a distal
CC       site that can bind a second membrane. These structural features
CC       correlate with the phosphatidylinositol 4-phosphate (PI(4)P)-coupled
CC       lipid transport optimized in closely apposed membranes, such as
CC       organelle contact sites. The lipid transfer cycle starts from the
CC       association of the LTP with a donor membrane, which accompanies
CC       conformational changes that uncover the ligand-binding pocket. The
CC       tunnel opening is generally mediated by displacement of the lid
CC       covering the binding pocket allowing uptake or release of a lipid
CC       molecule. The LTPs extract the lipid from the membrane by providing a
CC       hydrophobic environment as well as specific interaction. Dissociation
CC       from the donor membrane shifts the conformation to a closed form. Then,
CC       the LTPs loaded with a cargo lipid diffuse through the aqueous phase.
CC       Lid opening may be induced by the interaction of a hydrophobic side of
CC       the lid with the target membranes. {ECO:0000305|PubMed:20008566}.
CC   -!- MISCELLANEOUS: Present with 2550 molecules/cell in log phase SD medium.
CC       {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the OSBP family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X65124; CAA46249.1; -; Genomic_DNA.
DR   EMBL; Z28228; CAA82073.1; -; Genomic_DNA.
DR   EMBL; BK006944; DAA09159.1; -; Genomic_DNA.
DR   PIR; S25324; S25324.
DR   RefSeq; NP_012928.1; NM_001179793.1.
DR   PDB; 4B2Z; X-ray; 1.95 A; A/B=1-448.
DR   PDB; 4PH7; X-ray; 2.55 A; A/B/C/D=1-448.
DR   PDBsum; 4B2Z; -.
DR   PDBsum; 4PH7; -.
DR   AlphaFoldDB; Q02201; -.
DR   SMR; Q02201; -.
DR   BioGRID; 34135; 91.
DR   IntAct; Q02201; 24.
DR   MINT; Q02201; -.
DR   STRING; 4932.YKR003W; -.
DR   SwissLipids; SLP:000000525; -.
DR   TCDB; 2.D.1.1.3; the pi4p/ps counter transporter (p/p-ct) family.
DR   iPTMnet; Q02201; -.
DR   MaxQB; Q02201; -.
DR   PaxDb; Q02201; -.
DR   PRIDE; Q02201; -.
DR   EnsemblFungi; YKR003W_mRNA; YKR003W; YKR003W.
DR   GeneID; 853872; -.
DR   KEGG; sce:YKR003W; -.
DR   SGD; S000001711; OSH6.
DR   VEuPathDB; FungiDB:YKR003W; -.
DR   eggNOG; KOG2210; Eukaryota.
DR   GeneTree; ENSGT00940000154690; -.
DR   HOGENOM; CLU_012334_4_2_1; -.
DR   InParanoid; Q02201; -.
DR   OMA; EISGKWS; -.
DR   BioCyc; YEAST:G3O-31981-MON; -.
DR   PRO; PR:Q02201; -.
DR   Proteomes; UP000002311; Chromosome XI.
DR   RNAct; Q02201; protein.
DR   GO; GO:0032541; C:cortical endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:SGD.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0019898; C:extrinsic component of membrane; IDA:SGD.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008289; F:lipid binding; IDA:SGD.
DR   GO; GO:0070300; F:phosphatidic acid binding; IDA:SGD.
DR   GO; GO:0043325; F:phosphatidylinositol-3,4-bisphosphate binding; IDA:SGD.
DR   GO; GO:0080025; F:phosphatidylinositol-3,5-bisphosphate binding; IDA:SGD.
DR   GO; GO:0070273; F:phosphatidylinositol-4-phosphate binding; IDA:UniProtKB.
DR   GO; GO:0010314; F:phosphatidylinositol-5-phosphate binding; IDA:SGD.
DR   GO; GO:0001786; F:phosphatidylserine binding; IDA:UniProtKB.
DR   GO; GO:0005548; F:phospholipid transporter activity; IDA:UniProtKB.
DR   GO; GO:0032934; F:sterol binding; IBA:GO_Central.
DR   GO; GO:0120015; F:sterol transfer activity; IDA:SGD.
DR   GO; GO:0015248; F:sterol transporter activity; IBA:GO_Central.
DR   GO; GO:0006897; P:endocytosis; IGI:SGD.
DR   GO; GO:0006887; P:exocytosis; IGI:SGD.
DR   GO; GO:0030011; P:maintenance of cell polarity; IGI:SGD.
DR   GO; GO:0015914; P:phospholipid transport; IDA:UniProtKB.
DR   GO; GO:0034727; P:piecemeal microautophagy of the nucleus; IGI:SGD.
DR   GO; GO:0055092; P:sterol homeostasis; IMP:SGD.
DR   GO; GO:0016125; P:sterol metabolic process; IGI:SGD.
DR   GO; GO:0015918; P:sterol transport; IGI:SGD.
DR   InterPro; IPR037239; OSBP_sf.
DR   InterPro; IPR000648; Oxysterol-bd.
DR   InterPro; IPR018494; Oxysterol-bd_CS.
DR   PANTHER; PTHR10972; PTHR10972; 1.
DR   Pfam; PF01237; Oxysterol_BP; 1.
DR   SUPFAM; SSF144000; SSF144000; 1.
DR   PROSITE; PS01013; OSBP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Cytoplasm; Endoplasmic reticulum;
KW   Lipid transport; Lipid-binding; Membrane; Phosphoprotein;
KW   Reference proteome; Transport.
FT   CHAIN           1..448
FT                   /note="Oxysterol-binding protein homolog 6"
FT                   /id="PRO_0000100390"
FT   REGION          1..42
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          54..391
FT                   /note="OSBP-related domain (ORD)"
FT                   /evidence="ECO:0000305"
FT   COMPBIAS        12..30
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         64..69
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol
FT                   4-phosphate)"
FT                   /ligand_id="ChEBI:CHEBI:58178"
FT                   /evidence="ECO:0000269|PubMed:26206936,
FT                   ECO:0007744|PDB:4PH7"
FT   BINDING         64..69
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-L-serine"
FT                   /ligand_id="ChEBI:CHEBI:57262"
FT                   /evidence="ECO:0000269|PubMed:23934110,
FT                   ECO:0007744|PDB:4B2Z"
FT   BINDING         126..129
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol
FT                   4-phosphate)"
FT                   /ligand_id="ChEBI:CHEBI:58178"
FT                   /evidence="ECO:0000269|PubMed:26206936,
FT                   ECO:0007744|PDB:4PH7"
FT   BINDING         129
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-L-serine"
FT                   /ligand_id="ChEBI:CHEBI:57262"
FT                   /evidence="ECO:0000269|PubMed:23934110,
FT                   ECO:0007744|PDB:4B2Z"
FT   BINDING         157..158
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol
FT                   4-phosphate)"
FT                   /ligand_id="ChEBI:CHEBI:58178"
FT                   /evidence="ECO:0000269|PubMed:26206936,
FT                   ECO:0007744|PDB:4PH7"
FT   BINDING         183
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-L-serine"
FT                   /ligand_id="ChEBI:CHEBI:57262"
FT                   /evidence="ECO:0000269|PubMed:23934110,
FT                   ECO:0007744|PDB:4B2Z"
FT   BINDING         351
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol
FT                   4-phosphate)"
FT                   /ligand_id="ChEBI:CHEBI:58178"
FT                   /evidence="ECO:0000269|PubMed:26206936,
FT                   ECO:0007744|PDB:4PH7"
FT   BINDING         355
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol
FT                   4-phosphate)"
FT                   /ligand_id="ChEBI:CHEBI:58178"
FT                   /evidence="ECO:0000269|PubMed:26206936,
FT                   ECO:0007744|PDB:4PH7"
FT   BINDING         359
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol
FT                   4-phosphate)"
FT                   /ligand_id="ChEBI:CHEBI:58178"
FT                   /evidence="ECO:0000269|PubMed:26206936,
FT                   ECO:0007744|PDB:4PH7"
FT   MOD_RES         16
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17287358"
FT   MUTAGEN         69
FT                   /note="L->A,D: Strongly reduced binding to
FT                   phosphatidylserine."
FT                   /evidence="ECO:0000269|PubMed:23934110"
FT   MUTAGEN         69
FT                   /note="L->D: Strongly reduced binding to phosphatidylserine
FT                   and phosphatidylinositol 4-phosphate (PI4P)."
FT                   /evidence="ECO:0000269|PubMed:26206936"
FT   MUTAGEN         69
FT                   /note="L->F: Does not affect binding to
FT                   phosphatidylserine."
FT                   /evidence="ECO:0000269|PubMed:23934110"
FT   MUTAGEN         71
FT                   /note="T->P: Abolished binding to phosphatidylserine."
FT                   /evidence="ECO:0000269|PubMed:23934110"
FT   MUTAGEN         73
FT                   /note="I->D: Strongly reduced binding to
FT                   phosphatidylserine."
FT                   /evidence="ECO:0000269|PubMed:23934110"
FT   MUTAGEN         126
FT                   /note="K->A: Strongly reduced binding to
FT                   phosphatidylserine."
FT                   /evidence="ECO:0000269|PubMed:23934110"
FT   MUTAGEN         129
FT                   /note="N->A: Strongly reduced binding to
FT                   phosphatidylserine."
FT                   /evidence="ECO:0000269|PubMed:23934110"
FT   MUTAGEN         157..158
FT                   /note="HH->AA: Strongly reduced binding to
FT                   phosphatidylinositol 4-phosphate (PI4P). Does not affect
FT                   binding to phosphatidylserine."
FT                   /evidence="ECO:0000269|PubMed:26206936"
FT   MUTAGEN         157
FT                   /note="H->A: Does not affect binding to
FT                   phosphatidylserine."
FT                   /evidence="ECO:0000269|PubMed:23934110"
FT   MUTAGEN         158
FT                   /note="H->A: Does not affect binding to
FT                   phosphatidylserine."
FT                   /evidence="ECO:0000269|PubMed:23934110"
FT   MUTAGEN         182
FT                   /note="K->A: Does not affect binding to
FT                   phosphatidylserine."
FT                   /evidence="ECO:0000269|PubMed:23934110"
FT   MUTAGEN         351
FT                   /note="K->A: Does not affect binding to
FT                   phosphatidylserine."
FT                   /evidence="ECO:0000269|PubMed:23934110"
FT   MUTAGEN         351
FT                   /note="K->E: Strongly reduced binding to
FT                   phosphatidylinositol 4-phosphate (PI4P). Does not affect
FT                   binding to phosphatidylserine."
FT                   /evidence="ECO:0000269|PubMed:26206936"
FT   HELIX           37..39
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   HELIX           45..55
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   HELIX           71..73
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   STRAND          74..78
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   HELIX           79..85
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   HELIX           90..98
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   HELIX           102..115
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   TURN            116..118
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   STRAND          122..124
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   STRAND          126..128
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   STRAND          135..141
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   STRAND          147..156
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   TURN            157..160
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   STRAND          161..168
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   HELIX           169..171
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   STRAND          173..179
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   STRAND          181..185
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   STRAND          187..194
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   STRAND          197..206
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   STRAND          210..218
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   STRAND          222..225
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   STRAND          227..230
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   STRAND          233..236
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   STRAND          238..243
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   STRAND          248..253
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   STRAND          258..260
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   STRAND          263..271
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   STRAND          277..284
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   STRAND          287..293
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   STRAND          302..306
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   TURN            307..309
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   HELIX           320..322
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   HELIX           328..331
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   HELIX           333..340
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   HELIX           344..367
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   STRAND          375..379
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   STRAND          387..392
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   HELIX           400..410
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   HELIX           421..424
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   HELIX           427..433
FT                   /evidence="ECO:0007829|PDB:4B2Z"
FT   HELIX           436..440
FT                   /evidence="ECO:0007829|PDB:4PH7"
SQ   SEQUENCE   448 AA;  51588 MW;  44C4E16CF320DB78 CRC64;
     MGSKKLTVGS DSHRLSKSSF SSNKSSHSAT KDQPIDTDDI DEDDESGHNI ILNIISQLRP
     GCDLTRITLP TFILEKKSML ERVTNQLQFP EFLLQAHSEK DPLKRFLYVM KWYLAGWHIA
     PKAVKKPLNP VLGEYFTAYW DLPNKQQAYY ISEQTSHHPP ECAYFYMIPE SSIRVDGVVI
     PKSRFLGNSS AAMMDGSTVL QFLDIKDGNG KPEKYVLTQP NVYVRGILFG KMRIELGDHM
     IIKSPNFQAD IEFKTKGYVF GTYDAIEGTV KDYDGNAYYE ISGKWNDVMY LKDLKQPRSS
     PKVFLDTHKE SPLRPKVRPL SEQGEYESRK LWKKVTDALA VRNHPVATEE KFQIEDHQRQ
     LAKKRIEDGV EFHPKLFRRS KPGEDLDYCI YKNIPVDEDP EKQIRSILQI APILPGQQFT
     DKFFIPAFEK IKSQKKMIEN EKQNPAKQ
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024